Investors
Share price
Press releases
EUROAPI profile
With an industrial footprint all located in Europe and thanks to a wide range of advanced technologies, EUROAPI develops, manufactures, markets and distributes APIs and intermediates used in the formulation of medicines for human and veterinary use, both from originators and generics, through its API Solutions business and CDMO activities.
Through these activities, EUROAPI offers its customers a range of high value-added products and services to meet their commercial and regulatory needs. These customers include most of the major pharmaceutical companies, generic drug and animal health product manufacturers, consumer health and nutrition products companies, biotechnology companies and distribution companies.
EUROAPI’s strategy to further grow is focused on clear business and operational levers. We aim at accelerating our CDMO activities, expanding our differentiated presence with a particular emphasis on highly potent and complex APIs as well as tides, developing our product portfolio and realizing standalone efficiencies.
Key figures
-
150
years of experience in the API market
-
€1,013 m
of revenue in 2023
-
~200
APIs
-
~530
customers in 80+ countries
-
~330
employees in its R&D team dedicated to industrial process development
-
~3,650
employees